Sarcopenia and Menopause: The Role of Estradiol
During aging and menopausal transition in women, a progressive muscle degeneration (i.e. decrease in quality and muscle function) occurs. This muscle dysfunction, caused by decreased proliferation of muscle satellite cells, increased levels of inflammatory markers, and altered levels of sex hormones...
Main Authors: | Annalisa Geraci, Riccardo Calvani, Evelyn Ferri, Emanuele Marzetti, Beatrice Arosio, Matteo Cesari |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2021.682012/full |
Similar Items
-
Role of Age-Related Mitochondrial Dysfunction in Sarcopenia
by: Evelyn Ferri, et al.
Published: (2020-07-01) -
Nutritional Status as a Mediator of Fatigue and Its Underlying Mechanisms in Older People
by: Domenico Azzolino, et al.
Published: (2020-02-01) -
SARCOPENIA AND PHYSICAL FRAILTY: TWO SIDES OF THE SAME COIN
by: Matteo eCesari, et al.
Published: (2014-07-01) -
Biomarkers of Physical Frailty and Sarcopenia: Coming up to the Place?
by: Anna Picca, et al.
Published: (2020-08-01) -
Hot flush values of gonadotropins and estradiol in menopause
by: Arizanović Zorana, et al.
Published: (2018-01-01)